Kayo Ichihashi

发表

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics

T. Onitsuka, K. Ohi, N. Yasui-Furukori, 2022, Frontiers in Psychiatry.

Anti-stigma training and positive changes in mental illness stigma outcomes in medical students in ten countries: a mediation analysis on pathways via empathy development and anxiety reduction

K. Kasai, A. Olagunju, G. Thornicroft, 2022, Social Psychiatry and Psychiatric Epidemiology.

The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.

K. Kasai, T. Kishimoto, Tadasu Horai, 2022, Asian journal of psychiatry.

Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study.

T. Onitsuka, K. Ohi, N. Yasui-Furukori, 2022, Asian journal of psychiatry.

Anti-stigma training and positive changes in mental illness stigma outcomes in medical students in ten countries: a mediation analysis on pathways via empathy development and anxiety reduction

K. Kasai, A. Olagunju, G. Thornicroft, 2022, Social Psychiatry and Psychiatric Epidemiology.

Oral corticosteroid dosage and clinical presentation of psychiatric conditions after steroid use: A consultation‐liaison psychiatry service’s experience

K. Kasai, Yuko Yagi, Yousuke Kumakura, 2021, Neuropsychopharmacology reports.

Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study

T. Onitsuka, T. Kishimoto, K. Ohi, 2022, The international journal of neuropsychopharmacology.

Retrospective chart review‐based assessment scale for adverse childhood events and experiences

Sho Yagishita, K. Kasai, S. Koike, 2022, Psychiatry and Clinical Neurosciences Reports.

Unmet needs of patients with major depressive disorder – Findings from the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

T. Onitsuka, T. Kishimoto, Tadasu Horai, 2020, Psychiatry and clinical neurosciences.

A randomized controlled study of an e-learning program (YURAIKU-PRO) for public health nurses to support parents with severe and persistent mental illness and their family members

K. Nemoto, M. Kageyama, K. Yokoyama, 2022, BMC Nursing.

The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the “Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)” project

T. Onitsuka, T. Kishimoto, K. Ohi, 2022, Annals of General Psychiatry.

Betaine supplementation improves positive symptoms in schizophrenia

K. Kasai, M. Itokawa, Taiga Hosokawa, 2022, Schizophrenia Research.

Responding to experienced and anticipated discrimination (READ): anti -stigma training for medical students towards patients with mental illness – study protocol for an international multisite non-randomised controlled study

K. Kasai, A. Olagunju, G. Thornicroft, 2019, BMC Medical Education.

A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project

T. Onitsuka, T. Kishimoto, K. Ohi, 2022, BJPsych Open.

Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

T. Onitsuka, T. Kishimoto, K. Ohi, 2019, Psychiatry and clinical neurosciences.

Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders

T. Onitsuka, T. Kishimoto, Tadasu Horai, 2022, Neuropsychopharmacology reports.

Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia”

T. Onitsuka, T. Kishimoto, K. Ohi, 2022, Neuropsychopharmacology reports.

Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score‐matched analysis

Y. Hirano, Tadasu Horai, K. Ohi, 2022, Psychiatry and clinical neurosciences.

Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.

K. Miura, K. Ohi, Y. Takaesu, 2021, Asian journal of psychiatry.

Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project

T. Onitsuka, T. Kishimoto, Tadasu Horai, 2020, Neuropsychopharmacology reports.

Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia.

T. Onitsuka, K. Ohi, Y. Takaesu, 2022, Journal of clinical psychopharmacology.

Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics

Y. Hirano, T. Onitsuka, K. Ohi, 2023, Journal of clinical psychopharmacology.

A randomized controlled trial of comprehensive early intervention care in patients with first-episode psychosis in Japan: 1.5-year outcomes from the J-CAP study.

K. Kasai, S. Koike, T. Natsubori, 2018, Journal of psychiatric research.

Comprehensive early intervention for patients with first-episode psychosis in Japan ( J-CAP ) : study protocol for a randomised controlled trial

K. Kasai, S. Koike, T. Natsubori, 2011 .

Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project

T. Onitsuka, T. Kishimoto, K. Ohi, 2023, BMC Psychiatry.

Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry

T. Onitsuka, T. Kishimoto, K. Ohi, 2022, Neuropsychopharmacology reports.

Hypotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study.

T. Onitsuka, K. Miura, K. Ohi, 2021, Sleep medicine.

Japanese Abstract

Y. Hirano, T. Onitsuka, T. Nakazawa, 2022, Psychiatry and Clinical Neurosciences.

Relationship between high trait anxiety in 22q11.2 deletion syndrome and the difficulties in medical, welfare, and educational services

K. Kasai, H. Ohashi, Y. Kano, 2023, Psychiatry and Clinical Neurosciences Reports.

Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study

T. Kishimoto, K. Ohi, N. Yasui-Furukori, 2023, Psychiatry and clinical neurosciences.

Comprehensive early intervention for patients with first-episode psychosis in Japan (J-CAP): study protocol for a randomised controlled trial

K. Kasai, S. Koike, T. Natsubori, 2011, Trials.